Clinical Trial Update: MRD-Adapted Low-Dose Radiation Therapy During Frontline Chemoimmunotherapy for Diffuse Large B-Cell Lymphoma [NA]

View source ↗

Summary

A clinical trial evaluating MRD-adapted low-dose radiation therapy during frontline chemoimmunotherapy for diffuse large B-cell lymphoma is currently not recrui…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma

Snippet

Sponsor: University of Nebraska | Conditions: Diffuse Large B-Cell Lymphoma | NA | Status: NOT_YET_RECRUITING